Approval · Notice of Compliance 23098 · 2020
VENCLEXTA: Notice of Compliance 23098
Issued January 13, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23098
- Date
- January 13, 2020
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of the post-apporoval commitments for the notice of compliance with conditions
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VENCLEXTA | Not yet assigned | — |
Medicinal ingredients
- VENETOCLAX 10 MG per TAB
- VENETOCLAX 50 MG per TAB
- VENETOCLAX 100 MG per TAB